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The circadian timing system plays a key role in orchestrating lipid metabolism. In concert with the solar cycle, the circadian system
ensures that daily rhythms in lipid absorption, storage, and transport are temporally coordinated with rest-activity and feeding cycles. At
the cellular level, genes involved in lipid synthesis and fatty acid oxidation are rhythmically activated and repressed by core clock proteins
in a tissue-specific manner. Consequently, loss of clock gene function or misalignment of circadian rhythms with feeding cycles (e.g., in
shift work) results in impaired lipid homeostasis. Herein, we review recent progress in circadian rhythms research using lipidomics, i.e.,
large-scale profiling of lipid metabolites, to characterize circadian-regulated lipid pathways in mammals. In mice, novel regulatory
circuits involved in fatty acid metabolism have been identified in adipose tissue, liver, and muscle. Extensive diversity in circadian
regulation of plasma lipids has also been revealed in humans using lipidomics and other metabolomics approaches. In future studies,
lipidomics platforms will be increasingly used to better understand the effects of genetic variation, shift work, food intake, and drugs on
circadian-regulated lipid pathways and metabolic health.
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In most mammals, behavioral and physiologic rhythms are
synchronized with the solar cycle. These rhythms are regulated
by the circadian (“about a day”) system, which temporally co-
ordinates energy intake and expenditure across the day. To better
understand the role of the circadian clock in regulating lipid
metabolism, an increasing number of studies have used large-
scale profiling of lipids (i.e., lipidomics) to analyze biological
specimens collected across the circadian cycle. A major goal of
lipidomics research is to understand how lipid networks and
pathways respond to changes in the environment. Recentccess article under the CC BY-NC-ND license (http://
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16/j.jgg.2014.04.001advances in mass spectrometry have made it possible to deter-
mine the concentrations of hundreds of lipids that make up the
lipidome in a single biological specimen. Here, we review recent
progress in circadian rhythms research using lipidomics ap-
proaches, which we shall henceforth refer to as “circadian lip-
idomics”.Webeginwith an overviewof how the circadian system
is hierarchically organized to coordinate metabolic rhythms in
peripheral tissues with rest-activity and feeding cycles. This is
followed by a discussion of molecular mechanisms that couple
the core clock to lipid pathways, as well as metabolic abnor-
malities associated with dysregulated clock function. In different
metabolic tissues, we give examples of how the circadian clock
regulates lipid synthesis and fatty acid oxidation, cholesterol and
bile acid homeostasis, and lipid absorption and secretion. In the
second part of the review, we focus on studies that have used
lipidomics or other metabolomics approaches to identify novel
circuits regulating fatty acid metabolism in adipose tissue, liver,mental Biology, Chinese Academy of Sciences, and Genetics Society of China.
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the circadian time-course of lipid concentrations in human
plasma using metabolomics and lipidomics platforms. Finally,
we review the clinical relevance of circadian-regulated lipid
pathways, with an emphasis on shift work, obesity, and treatment
of metabolic disorders. We discuss limitations of studies con-
ducted thus far, and how circadian lipidomics can be applied to
improve our understanding of genetic and environmental factors
that influence lipid metabolism.
ORGANIZATION OF THE CIRCADIAN TIMING
SYSTEMCircadian rhythms play an adaptive roleThe circadian timing system regulates daily rhythms of
behavior and physiology, including the sleep-wake cycle and
endocrine function. Even in the absence of periodic environ-
mental time cues, the circadian system generates near-24-hour
rhythms of activity, demonstrating the existence of an
endogenous time-keeping mechanism (Czeisler and Gooley,
2007). Under natural conditions, as the Earth turns on its
axis, exposure to alternating cycles of light and darkness
synchronizes circadian rhythms, ensuring that foraging
behavior and metabolic function are temporally coordinated
with the solar cycle and food availability. The circadian sys-
tem therefore provides an internal representation of day and
night, allowing the body to anticipate daily changes in the
environment. Perhaps the most overt manifestation of this is
the sleep-wake cycle. For a person who is normally entrained
to the solar cycle, synthesis of the sleep-promoting hormone
melatonin usually begins a few hours before bedtime (Scheer
and Czeisler, 2005). Circulating melatonin levels are highest
during the middle of the night and then decrease prior to usual
wake time. In parallel, the circadian rhythm of plasma cortisol
is low during the early part of the night and rises sharply
before wake time, presumably to prepare the body for daytime
activity and associated metabolic demands (Czeisler and
Klerman, 1999). Circadian rhythms of melatonin and
cortisol are therefore aligned with the solar cycle to promote
sleep during the night and wakefulness during the daytime.
The ability of the circadian system to anticipate changes in the
environment is thought to confer increased reproductive
fitness. This view is supported by studies performed in species
ranging from cyanobacteria to plants to mammals (Ouyang
et al., 1998; DeCoursey et al., 2000; Green et al., 2002). As
discussed below, misalignment of the circadian system with
rest-activity and feeding cycles results in metabolic dysfunc-
tion and increased morbidity. Such findings suggest that the
circadian system facilitates behavioral and physiologic adap-
tation to daily environmental cycles to maintain energy
balance, and thus increases survival.Hierarchical control of circadian rhythmsThe circadian timing system is thought to be hierarchically
organized (Fig. 1). The master circadian clock is located in thesuprachiasmatic nucleus (SCN) in the anterior hypothalamus.
Lesions that include the SCN or its efferent projections elimi-
nate circadian patterns of behavior and endocrine rhythms
(Saper et al., 2005). More than 40 years ago, it was shown that
SCN ablation results in loss of the adrenal corticosterone
rhythm in rats (Moore and Eichler, 1972), demonstrating that
the master clock plays an important role in regulating physio-
logic rhythms in peripheral tissues. Decades later, it was shown
that circadian clocks are found in tissues throughout the body,
including but not limited to metabolic organs (Yamazaki et al.,
2000; Fukuhara and Tosini, 2003). Damage to the SCN causes
peripheral clocks to fall out of synchrony, yet individual cells
retain the capacity to generate circadian oscillations in gene
transcription (Yoo et al., 2004). As such, the SCN has been
likened to the conductor of an orchestra e without the
conductor, the individual musicians can continue to play, but
the rhythm would soon be lost if the players could not rely on
other cues to keep them in synch. As shown in SCN-lesioned
mice, which display arrhythmic patterns of activity and food
intake, loss of synchronicity results in metabolic dysfunction,
including an increase in fat mass and severe hepatic insulin
resistance (Coomans et al., 2013). Interestingly enough, there
are SCN-independent time cues that can keep peripheral
circadian clocks synchronized, namely feeding cycles. In
nocturnal rodents that are given daily restricted access to food
only during the daytime (i.e., their usual inactive phase),
circadian rhythms in peripheral tissues synchronize to the
fasting-feeding cycle, even when the SCN clock remains syn-
chronized to the light-dark cycle (Damiola et al., 2000). When
food is available ad libitum, however, SCN-driven rhythms of
endocrine function, behavioral activity, and feeding are thought
to entrain peripheral clocks, thus coordinating circadian
metabolic function with daily foraging behavior.The molecular circadian clockCircadian rhythms are generated at the cellular level by
transcriptional-translational feedback loops that are highly
conserved across different cell types (Fig. 2). In SCN neurons,
the transcription factors brain and muscle aryl hydrocarbon
receptor translocator-like protein 1 (BMAL1, also known as
MOP3 or Arnt3) and circadian locomotor output cycles kaput
(CLOCK) form a heterodimer during the daytime and activate
the Period (Per1 and Per2) and Cryptochrome (Cry1 and Cry2)
genes by binding to E-box sequences in the promoter region
(Gekakis et al., 1998; Kume et al., 1999; Bunger et al., 2000;
Zheng et al., 2001). Whereas CLOCK is the primary binding
partner for BMAL1 in the SCN, in other brain regions and in
peripheral tissues, neuronal PAS domain-containing protein 2
(NPAS2) can heterodimerize with BMAL1 to activate Per and
Cry genes (Reick et al., 2001). The PER and CRY proteins
accumulate in the cytoplasm during the daytime, and then
translocate to the nucleus in the evening to repress their own
transcription by interacting with the CLOCK/NPAS2:BMAL1
complex (Griffin, Jr. et al., 1999; Kume et al., 1999; Lee et al.,
2001; Sato et al., 2006). The near-24-hour time-course of this
negative feedback loop is regulated by posttranslational
Fig. 1. Hierarchical organization of the circadian system.
The master clock in the suprachiasmatic nucleus (SCN) is normally synchronized with the solar cycle through the activation of intrinsically-photosensitive retinal
ganglion cells (ipRGCs). The SCN, in turn, synchronizes behavioral and endocrine rhythms to temporally coordinate circadian clocks located in peripheral tissues.
Exposure to feeding-fasting cycles can also entrain clocks in metabolic tissues independent of the SCN neural activity rhythm. Open-source clipart images were
downloaded from www.openclipart.org and www.clker.com.
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tion and proteosomal degradation of PER and CRY proteins
(Eide et al., 2005; Shirogane et al., 2005; Godinho et al., 2007;
Siepka et al., 2007; Yoo et al., 2013), which allows for a new
cycle of transcription by relieving inhibition of the CLOCK/
NPAS2:BMAL1 complex. In a second molecular feedback
loop, the CLOCK:BMAL1 heterodimer activates transcription
of the nuclear receptors, Rev-erba and Rev-erbb, whose pro-
tein products repress Bmal1 expression (Preitner et al., 2002).
The retinoic acid receptor-related orphan receptor (RORa,
RORb, and RORg) genes are also rhythmically transcribed, but
RORs cycle in anti-phase to REV-ERBs and activate Bmal1
transcription (Sato et al., 2004; Akashi and Takumi, 2005).
REV-ERBa also represses Npas2 expression (Crumbley et al.,
2010), whereas RORa and RORg activate Npas2 transcription
(Takeda et al., 2011). To be sure, there are other mechanisms
and pathways that regulate circadian timing at the cellular
level, as reviewed in detail elsewhere (Lowrey and Takahashi,
2011; Sahar and Sassone-Corsi, 2012), but the feedback loops
described above constitute part of the core molecular clock
mechanism.Resetting of circadian clocksThe finding that peripheral clocks can become uncoupled
from the SCN rhythm, e.g., in response to shifting the timing of
food availability, suggests that different mechanisms underlie
entrainment of these clocks. Under normally entrainedconditions, the SCN neural activity rhythm is highest during the
daytime and lowest at night (Yamazaki et al., 1998). Exposure to
light at night increases SCN neural activity and resets the phase
of the master clock (Takasu et al., 2013). The direction and
magnitude of resetting depends on internal body time (i.e.,
circadian phase) that the light stimulus occurs. In general,
exposure to light in the evening and early part of the night resets
the phase of the SCN clock in the westward direction (phase
delay shift), whereas exposure to light in the later part of the
night and earlymorning resets the clock in the eastward direction
(phase advance shift) (Gooley, 2008). Light resetting of circa-
dian rhythms occurs via a direct retinal projection to the SCN
from intrinsically-photosensitive retinal ganglion cells
(ipRGCs) that contain the photopigment melanopsin (Gooley
et al., 2001; Berson et al., 2002; Hannibal et al., 2002; Hattar
et al., 2002). The ipRGCs can also be activated indirectly by
light activation of rod and cone photoreceptors in the outer
retina, even when melanopsin is rendered dysfunctional. Upon
activation, ipRGCs signal light information to SCN neurons by
releasing glutamate and pituitary adenylate cyclase-activating
polypeptide (PACAP) (Hannibal, 2006; Golombek and
Rosenstein, 2010). This triggers Ca2þ influx and activates
mitogen-activating protein kinase/extracellular signal-regulated
kinase (MAPK/ERK) and other signaling cascades (Meijer and
Schwartz, 2003), resulting in activation of cyclic adenosine
monophosphate (cAMP) response element-binding protein
(CREB) and CREB-regulated transcription coactivator 1
(CRTC1). Light activation of CREB:CRTC1 leads to induction
Fig. 2. Simplified model of the molecular circadian clock.
The transcription factors BMAL1 and CLOCK (or NPAS2, not shown) bind to E-boxes in the promoter region of Period (Per1 and Per2) and Cryptochrome (Cry 1
and Cry2) genes. PER and CRY proteins heterodimerize and translocate to the nucleus where they repress their own transcription by interacting with the
CLOCK:BMAL1 complex. The near-24-hour cycle is regulated by phosphorylation-dependent nuclear entry and degradation of PER and CRY proteins, which is
determined in part by casein kinase 1 (CK1ε and CK1d). In another feedback loop, the CLOCK:BMAL1 complex drives expression of Rev-erba and Rev-erbb
genes, whose protein products interact with NcoR and HDAC3 and repress transcription of Bmal1, Clock, and Npas2 by binding to RORE sequences in the
promoter region. RORs cycle in anti-phase to REV-ERBs and activate transcription of Bmal1, Clock, and Npas2. The core clock proteins rhythmically drive and/or
repress expression of clock-controlled genes that code for metabolic enzymes and other transcription factors.
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mechanism underlying circadian phase resetting of SCN neu-
rons (Albrecht et al., 1997; Schwartz et al., 2011). In addition,
CREB:CRTC1 induces expression of salt inducible kinase 1
(Sik1), whose protein product deactivates CRTC1, hence
limiting the magnitude of light resetting of the SCN clock
through a negative feedbackmechanism (Jagannath et al., 2013).
How, then, does the master clock synchronize peripheral
clocks? Despite the important role of the SCN in regulating
circadian physiology, the number of SCN efferent projections is
surprisingly limited. The densest projections from the SCN
terminate dorsally and caudally in the subparaventricular zone
and dorsomedial hypothalamus nucleus, both of which have
been implicated in circadian control of behavior and physi-
ology (Lu et al., 2001; Chou et al., 2003; Gooley et al., 2006).
Additionally, the SCN projects directly (and indirectly) to the
paraventricular hypothalamic nucleus, and it is through this
pathway that the clock regulates circadian rhythms of mela-
tonin and cortisol. The latter is of particular interest here, as
glucocorticoid signaling has been implicated in entrainment of
peripheral clocks. The synthetic glucocorticoid dexamethasonehas been shown to induce Period gene expression in fibroblasts,
and to reset the phase of circadian gene expression in peripheral
tissues including liver, heart, and kidney (Balsalobre et al.,
2000). Moreover, glucocorticoid receptor (GR) binding ele-
ments are found in Period genes, and GRmediates the initiation
and maintenance of dexamethasone-induced circadian gene
transcription in primary mesenchymal stem cells (So et al.,
2009). Glucocorticoid signaling also influences the rate of
entrainment of peripheral clocks to feeding cycles in mice
given access to food only during the daytime (Le Minh et al.,
2001). Although these studies demonstrate that peripheral
clocks can be reset by glucocorticoids, feeding cycles (SCN-
driven or imposed) can also potentially impact clock function
through nutrient-sensing pathways. For example, sirtuin 1
(SIRT1) is a nicotinamide adenine dinucleotide (NAD)þ-
dependent deacetylase that not only regulates gluconeogenesis
and cholesterol metabolism (Li et al., 2007; Schwer and Verdin,
2008), but also modulates circadian clock function by inter-
acting with core clock proteins (Asher et al., 2008; Nakahata
et al., 2008). Similarly, AMP-activated protein kinase
(AMPK), which is activated when cellular energy is low, can
235J.J. Gooley, E.C.-P. Chua / Journal of Genetics and Genomics 41 (2014) 231e250modulate clock function through phosphorylation-dependent
degradation of clock proteins (Um et al., 2007; Lamia et al.,
2009). Also, the finding that circadian-oscillating metabolites
such as cAMP, NADþ, and heme (a ligand for REV-ERBa and
b) modulate the molecular clock suggests that clock-controlled
outputs provide feedback to the clock itself to fine-tune phase
and amplitude (Sahar and Sassone-Corsi, 2012).Summary of circadian system organizationIn summary, the master clock in the SCN drives circadian
rhythms of behavior including the sleep-wake cycle and
feeding patterns. Circadian rhythms are generated at the
cellular level by a self-sustained molecular clock. Exposure to
alternating cycles of light and darkness synchronizes the SCN
clock, thereby aligning behavior with the solar cycle. The SCN
regulates rhythmic synthesis of endocrine factors, including
the release of glucocorticoids, which can potentially synchro-
nize peripheral clocks. Through its effects on feeding cycles,
the SCN can also coordinate the timing of peripheral cellular
oscillators. The circadian resetting effects of feeding-fasting
cycles on peripheral rhythms do not depend on SCN neural
activity, however, and nutrient-sensing pathways interact
directly with core molecular clock components. The circadian
system therefore allows for integration of light and feeding
cues to coordinate metabolic function in peripheral tissues.
CIRCADIAN REGULATION OF LIPID METABOLISMRegulation of clock-controlled genes involved in
metabolismThousands of genes show circadian expression patterns. In
fact, about a third of known genes in the mouse genome show
circadian oscillations in at least one tissue (Yan et al., 2008).
The set of circadian-controlled genes differs markedly across
tissues, however, indicating that circadian transcriptional pro-
grams are tissue-specific. The molecular circadian clock can
regulate metabolic pathways by rhythmically activating or
repressing clock-controlled genes involved in metabolism. This
is achieved, in part, by circadian regulation of rate-limiting
steps in metabolic pathways (Panda et al., 2002). For
example, in mouse liver, the circadian clock controls expres-
sion of the gluconeogenic enzyme, phosphoenolpyruvate
carboxylase, in addition to glucose transporters and glucagon
receptors. Rate-limiting steps of fatty acid oxidation are also
under circadian control in the liver, e.g., as reflected by cycling
mRNA levels of the fatty acid transporter carnitine-palmitoyl
transferase 1 (CPT-1). Similarly, circadian oscillations in
gene expression are observed for pathways involved in
cholesterol and bile acid homeostasis, including the biosyn-
thetic rate-limiting enzymes, 3-hydroxy-3-methyl-glutaryl-
Coenzyme A reductase (HMGCR) and cholesterol 7a-hy-
droxylase (CYP7A1). More generally, nuclear receptors, which
sense fat-soluble hormones and dietary lipids, are diurnally
regulated in metabolic tissues including white and brown adi-
pose tissue, liver, and muscle (Yang et al., 2006). Nuclearreceptors, including REV-ERBs and peroxisome proliferator-
activated receptors (PPARa, PPARg, and PPARd), couple
transcriptional networks involved in carbohydrate and lipid
metabolism with the molecular clock. As noted in the previous
section, REV-ERBs are core components of the molecular
clock itself, thus providing a direct mechanism for circadian
regulation of lipid metabolism via cyclic transcriptional
repression of metabolic genes.
A substantial proportion of oscillating transcripts are regu-
lated directly by the core molecular clock e this has been
shown in experiments using chromatin immunoprecipitation
combined with deep sequencing to identify genome-wide
binding targets (i.e., the cistrome) of clock proteins in mouse
liver. Thousands of DNA binding sites are rhythmically occu-
pied by BMAL1, including genes involved in carbohydrate and
lipid metabolism, transcriptional regulation, and the cell cycle
(Hatanaka et al., 2010; Rey et al., 2011). With respect to lipid
synthesis, sterol and triglyceride metabolic pathways are
especially enriched among BMAL1 targets in liver. Genome-
wide occupancy rhythms have also been examined for
REV-ERBa, which recruits the nuclear receptor corepressor
(NcoR)/histone deacetylase 3 (HDAC3) complex to repress
transcription of Bmal1 and other genes containing the ROR
element (RORE) motif. The cistromes for REV-ERBa, NcoR,
and HDAC3 show extensive overlap and are enriched for genes
involved in lipid metabolism (Feng et al., 2011; Bugge et al.,
2012; Cho et al., 2012). For example, REV-ERBa and
HDAC3 colocalize at more than a hundred lipid biosynthetic
genes, including fatty acid synthase, acetyl-CoA carboxylase,
and thyroid hormone-inducible hepatic protein (Feng et al.,
2011). In another comparative cistrome analysis, REV-ERBa,
REV-ERBb, and BMAL1 showed strong overlap in their
binding sites, with convergence for metabolic pathways and
transcriptional regulators (Cho et al., 2012). These findings
were confirmed and extended in a recent study that examined
the circadian rhythm of genome-wide occupancy for 7 of the
core clock proteins in mouse liver (BMAL1, CLOCK, NPAS2,
PER1, PER2, CRY1, and CRY2) (Koike et al., 2012). Together,
these studies demonstrate that the core molecular clock regu-
lates lipid metabolic pathways by activating or repressing
genes involved in lipid metabolism, either directly or by
regulating the cycling of other transcription factors.Loss of clock function is associated with abnormal
metabolic phenotypesAn important functional role for the molecular circadian
clock in metabolism has been confirmed using clock gene
mutant and null mice (Table 1). Behaviorally arrhythmic
ClockD19 mutant mice (on a C57BL/6J background) are hy-
perphagic and develop obesity, and this is accompanied by
hyperglycemia, hyperlipidemia, and hepatic steatosis (Turek
et al., 2005). Since Bmal1 null mice develop non-
inflammatory arthropathy in adulthood (Bunger et al., 2005),
resulting in progressive weight loss, reduced activity, and less
food and water intake, metabolic phenotyping in these animals
has been performed primarily in the first few months of
Table 1
Abnormal metabolic phenotypes in mice with clock gene mutations
Clock gene(s) Mutation Metabolic phenotype Reference
Clock Whole-body loss
of function
Obesity, hyperglycemia, hypoinsulinemia,
hypertriglyceridemia, enhanced insulin-
induced hypoglycemia, hepatic steatosis,
increased lipid absorption
Rudic et al., 2004; Turek et al., 2005;
Marcheva et al., 2010; Pan et al., 2010
Bmal1 Whole-body
knockout
Glucose intolerance, hypoinsulinemia,
enhanced insulin-induced hypoglycemia,
hyperlipidemia, increased ectopic fat in liver
and muscle
Rudic et al., 2004; Shimba et al., 2005,
2011; Lamia et al., 2008
L-Bmal1 Liver-specific
knockout
Fasting/daytime hypoglycemia, enhanced
insulin-induced hypoglycemia
Lamia et al., 2008
P-Bmal1 Pancreas-specific
knockout
Glucose intolerance, hypoinsulinemia Marcheva et al., 2010; Sadacca et al., 2011
Ad-Bmal1 Adipose-specific
knockout
Obesity, reduced circulating levels of
polyunsaturated fatty acids
Paschos et al., 2012
Per1
Per2
Whole-body
double knockout
Glucose intolerance, enhanced insulin-
induced hypoglycemia
Lamia et al., 2008
Per2 Whole-body
knockout
Reduced circulating triglycerides and free
fatty acids, increased adipogenesis and body
fat
Grimaldi et al., 2010
Cry1
Cry2
Whole-body
double knockout
Glucose intolerance, elevated circulating
corticosterone
Lamia et al., 2011
Rev-erba Whole-body
knockout
Altered hepatic triglyceride levels, increased
plasma cholesterol, reduced bile acid levels,
hepatic steatosis
Le Martelot et al., 2009; Feng et al., 2011
Rev-erba
Rev-erbb
Whole-body
double knockout
or loss of function
Hyperglycemia, hyperlipidemia, severe
hepatic steatosis
Bugge et al., 2012; Cho et al., 2012
Rora Whole-body loss
of function
Reduced plasma HDL and triglycerides,
reduced adiposity
Mamontova et al., 1998; Lau et al., 2008
236 J.J. Gooley, E.C.-P. Chua / Journal of Genetics and Genomics 41 (2014) 231e250development. Similar to ClockD19 mutant mice, animals with
loss of Bmal1 function are behaviorally arrhythmic and exhibit
hyperlipidemia (Rudic et al., 2004; Shimba et al., 2011).
BMAL1-deficient mice also show increased ectopic fat in liver
and muscle (Shimba et al., 2011) and increased total body fat
content prior to the onset of arthropathy (Lamia et al., 2008).
Whereas mice with whole-body loss of Bmal1 function show
impaired glucose tolerance and reduced circulating insulin,
animals with liver-specific deletion of Bmal1 exhibit hypo-
glycemia during fasting and greater clearance of glucose
despite normal insulin production (Lamia et al., 2008). On the
other hand, pancreas-specific loss of Bmal1 results in severe
glucose intolerance similar to whole-animal Bmal1/ mice,
despite normal circadian activity rhythms, feeding behavior,
and adiposity (Marcheva et al., 2010; Sadacca et al., 2011).
Relative to wild-type mice, animals with adipose-specific loss
of Bmal1 function consume a greater proportion of their daily
calories during the usual inactive phase, and this is associated
with increased weight gain and adipose tissue mass, as well as
a reduction in circulating polyunsaturated fatty acids (Paschos
et al., 2012). Homozygous staggerer mice (sg/sg), which
have an intragenic deletion in the coding region of RORa
(a transcriptional activator of Bmal1), show reduced adiposity,
decreased circulating levels of triglycerides and high-densitylipoprotein (HDL), and are protected against diet-induced
obesity (Mamontova et al., 1998; Lau et al., 2008). In
contrast, mice with loss of NPAS2, which partners with
BMAL1 in forebrain and peripheral tissues, do not show
robust changes in feeding behavior, weight gain, or responses
to metabolic challenges, perhaps due to functional redundancy
of CLOCK (Wu et al., 2010). The ability to adapt to daytime-
restricted feeding is impaired in Npas2/ mice, however,
which may be related to the role of NPAS2 in sensing cellular
metabolic state in response to feeding-fasting cycles (Dudley
et al., 2003; Wu et al., 2010). Additionally, based on a
comparative analysis of the transcriptome in Npas2/ mice
and wild-type animals, the primary dysregulated pathways in
NPAS2-deficient mice are lipid and fatty acid metabolism
pathways (O’Neil et al., 2013).
Transcriptional repressors of the core molecular clock have
also been implicated in metabolic dysfunction. Mice lacking
function of bothPer1 andPer2 show impaired glucose tolerance
and enhanced hypoglycemia following injection with insulin
(Lamia et al., 2008). Lipid metabolism is also altered in PER2-
deficient mice, which show a marked reduction in circulating
triglycerides and non-esterified fatty acids (Grimaldi et al.,
2010). Adipogenesis is increased in Per2/ mice, and this is
thought to occur through loss of PER2-mediated repression of
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proteins (Cry1//Cry2/) exhibit glucose intolerance and
constitutively high levels of circulating corticosterone, the
major glucocorticoid in rodents (Lamia et al., 2011). This is
mediated, at least in part, by loss of CRY repression of gluco-
corticoid receptor-mediated transcription. As a result, CRY-
deficient mice treated with dexamethasone show increased
expression of the gluconeogenic enzyme phosphoenolpyruvate
carboxykinase 1 (Pck1), as compared to wild-type mice. REV-
ERBa-deficient mice show deficits in cholesterol and bile acid
homeostasis, as reflected by increased plasma cholesterol and
reduced bile acid levels in the gallbladder relative to wild-type
mice (Le Martelot et al., 2009). In the same study, hepatic tri-
glycerides were lower in Rev-erba knockout mice; however, in
another study REV-ERBa-deficient mice exhibited elevated
liver triglycerides and modest hepatosteatosis (Feng et al.,
2011). Depletion of both REV-ERBa and REV-ERBb results
in a marked increase in liver triglycerides, severe steatosis, and
hyperglycemia (Bugge et al., 2012; Cho et al., 2012). Loss of
function of both REV-ERBs is also associated with reduced
diurnal recruitment of NcoR and HDAC3 to binding regions
near Bmal1 and Npas2 genes (Bugge et al., 2012). Considering
that mice with liver-specific depletion of HDAC3 showed
severe hepatic steatosis similar to REV-ERB-deficient mice
(Feng et al., 2011), these findings suggest that REV-ERB
mediated recruitment of HDAC3 is critical for diurnal repres-
sion of lipogenic genes and for temporally coordinating lipid
homeostasis with feeding cycles.Circadian regulation of lipid homeostasis in metabolic
tissuesThe liver clock plays a critical role in regulating energy
homeostasis. Below, we highlight just a few of the clock-
regulated pathways important for hepatic lipid metabolism.
Notably, all of the PPAR family members are under diurnal
control in mouse liver (Yang et al., 2006), including PPARa
which promotes fatty acid transport and mitochondrial fatty
acid b-oxidation. In mice, Ppara expression reaches its peak
near the beginning of the night, i.e., at the start of the active
phase, and cycles in phase with PPARg coactivator 1a (PGC-
1a). PGC-1a itself upregulates gene expression of Bmal1 and
Rev-erba through co-activation of RORs, hence regulating
circadian clock function (Liu et al., 2007). PGC-1a also in-
duces expression of lipin1, whose protein activates Ppara and
interacts directly with PPARa and PGC-1a (Finck et al.,
2006). The PPARa/PGC-1a/lipin1 regulatory module there-
fore oscillates in concert, promoting fatty acid oxidation at a
time when mice show an increase in locomotor activity and
food-seeking behavior (Li et al., 2012). By comparison, the
circadian clock regulates the timing of fatty acid synthesis, at
least in part, through regulation of the membrane-bound
transcription factor, sterol regulatory element-binding protein
(SREBP)-1c. Studies in Rev-erba null mice have confirmed an
important role for the molecular clock in regulating SREBP-1c
and its target genes including fatty acid synthase ( fas), fatty
acid desaturase 2 ( fads2), insulin-induced gene 1 (insig1), andelongation of long-chain fatty acids family member 6 (elovl6)
(Le Martelot et al., 2009). When anchored in the endoplasmic
reticulum membrane, SREBPs are bound by SREBP-cleavage
activating protein (SCAP), and this complex is sequestered by
INSIG-1 and INSIG-2 proteins in a sterol-dependent manner.
At low sterol levels, the SCAP-SREBP complex is released
and transported to Golgi vesicles where SREBP undergoes
proteolytic cleavage, followed by translocation to the nucleus
where it can activate genes involved in fatty acid synthesis
(and cholesterol synthesis, as discussed below) (Horton et al.,
2002). The expression of Insig genes is under diurnal control
and regulated by REV-ERBa (Le Martelot et al., 2009),
providing a putative mechanism by which the core molecular
clock modulates SREBP-1c activity and hence the diurnal
time-course of fatty acid synthesis. Similarly, circadian regu-
lation of the INSIG-SCAP-SREBP pathway is thought to co-
ordinate cholesterol homeostasis. In REV-ERB-a deficient
mice, as well as transgenic mice engineered to over-express
REV-ERB-a in hepatocytes, circadian gene expression is
altered for Hmgcr and low-density lipoprotein receptor (Ldlr),
suggesting an important role for the clock in regulating
cholesterol synthesis and transport (Le Martelot et al., 2009).
Bile acid synthesis from cholesterol is also diurnally regulated,
and this is dependent on circadian regulation of the rate-
limiting enzyme, CYP7A. In mice, expression of Cyp7a1
reaches its highest levels during the early part of the night,
thus promoting bile acid synthesis and emulsification of
dietary lipids when the majority of food is consumed.
The circadian clock is also important for regulating the
function of adipose tissue, where the majority of fat is stored.
For example, adipose-derived hormones show circadian vari-
ation including the appetite-suppressant leptin (Shea et al.,
2005), which signals postprandial satiety to appetite circuits
in the hypothalamus to reduce food intake. In wild-type mice,
adipose triglyceride lipase (Atgl ) and hormone-sensitive lipase
(Hsl ) genes are activated directly by the CLOCK:BMAL1
transcriptional complex (Shostak et al., 2013). In ClockD19
mutant mice, mRNA levels for these rate-limiting lipolytic
enzymes are reduced, which presumably contributes to
increased lipid accumulation in white adipose tissue in these
animals. Circadian rhythms of nuclear receptor activation also
likely play an important role in coupling the core molecular
clock with lipid metabolic function in adipose tissue. For
example, PPARg is circadian-regulated and plays a key role in
adipogenesis and stimulating lipid uptake by adipocytes
(Lehrke and Lazar, 2005; Yang et al., 2006). PPARg regulates
gene expression of Rev-erba in adipocytes (Fontaine et al.,
2003), and adipose-specific loss of PPARg function results
in adipocyte hypocellularity and hypertrophy, in addition to
elevated levels of free fatty acids and triglycerides in plasma
(He et al., 2003). Notably, targeted activation of PPARg with
anti-diabetic thiazolidinediones, or systemic treatment with
REV-ERBa agonists, improves dyslipidemia and hyperglyce-
mia (Lehmann et al., 1995; Solt et al., 2012). As discussed
above, PER2 has also been implicated in circadian regulation
of PPARg activity in adipose tissue (Grimaldi et al., 2010),
and whole-body Bmal1 knockout mice show deficits in
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et al., 2011). Moreover, recent evidence in mice indicates
that REV-ERBa is required for normal thermogenic responses
and cycling of body temperature through the regulation of
brown adipose tissue function (Gerhart-Hines et al., 2013).
In skeletal muscle, the majority of circadian-regulated
metabolic transcripts code for proteins involved in lipid ho-
meostasis (McCarthy et al., 2007). This includes nuclear re-
ceptors and their co-regulators, e.g., RORa, REV-ERBb, and
PGC-1b. PGC-1b binds to estrogen-related receptor, which
activates expression of medium chain acyl-CoA dehydroge-
nase (Mcad ), whose protein plays a key role in mitochondrial
fatty acid b-oxidation (Kamei et al., 2003). The skeletal
muscle-specific transcription factor myogenic differentiation
protein (MyoD) is regulated directly by the CLOCK:BMAL1
transcriptional complex, and hence exhibits circadian variation
in mRNA levels (Andrews et al., 2010). In the presence of
MyoD, PPARa and PPARd upregulate gene expression of the
muscle-specific transporter uncoupling protein-3 (Ucp3) by
fatty acids (Solanes et al., 2003). Expression of Ucp3 itself is
under circadian control, and is thought to facilitate fatty acid
oxidation (MacLellan et al., 2005; McCarthy et al., 2007).
Therefore, the core molecular clock can potentially regulate
fatty acid metabolism in skeletal muscle through its effects on
MyoD and UCP3 levels. Several genes involved in the syn-
thesis of fatty acids or cholesterol also show circadian regu-
lation in skeletal muscle including pantothenate kinase 1
(Pank1), the rate-limiting enzyme in CoA synthesis; diglyc-
eride acyltransferase 2 (Dgat2), which catalyzes the final step
in triglyceride synthesis; and acetyl-CoA acetyltransferase
(Acat2), an enzyme that regulates cholesterol absorption and
synthesis (McCarthy et al., 2007). A subset of genes involved
in hydrolysis of intracellular triglycerides is also rhythmic in
muscle, including carboxylesterase 3 (Ces3) and patatin-like
phospholipase domain-containing protein-3 (Pnpla3).
In addition to its role in regulating lipid homeostasis in
liver, adipose tissue, and muscle, the circadian clock regulates
lipid absorption by enterocytes (Hussain and Pan, 2012).
Dietary lipids are emulsified by bile salts and hydrolyzed by
pancreatic lipase to convert triglycerides to free fatty acids and
monoglycerides. These lipids are then taken up by enterocytes,
used to re-synthesize triglyceride, and packaged into chylo-
micron lipoprotein particles that are released into lymphatic
vessels and eventually the bloodstream. In the small intestine
of ClockD19 mutant mice, diurnal transcription of genes
involved in lipid absorption and transport is altered, and lipid
absorption is increased during the daytime relative to wild-
type mice (Pan and Hussain, 2009). Recent evidence sug-
gests that this is mediated by loss of cycling of microsomal
triglyceride transfer protein (MTP), a lipid chaperone that
plays a central role in apoB-lipoprotein assembly (Hussain
et al., 2012). CLOCK/NPAS2:BMAL1 activates expression
of small heterodimer partner (Shp), whose protein is thought to
suppress Mtp expression by interacting with transcription
factors that bind to MTP (Pan et al., 2010). Therefore, when
levels of SHP are high, MTP levels are reduced, resulting in
lower lipid absorption. In ClockD19 mice, reduced activation ofShp results in increased transcription of Mtp and lipid ab-
sorption, which presumably contributes to higher circulating
levels of triglycerides. Similarly, Shp/ mice exhibit elevated
Mtp mRNA levels, sustained hypertriglyceridemia, and higher
plasma levels of apoB48 and apoB100, which are the primary
apolipoproteins of chylomicrons and low-density lipoprotein,
respectively. These findings provide a putative mechanism for
circadian clock-regulated lipid absorption, which presumably
works in concert with circadian control of bile acid synthesis,
to coordinate emulsification and lipolysis of dietary tri-
glycerides. Recently, a parallel circadian-regulated pathway
was described for trafficking of dietary lipids in enterocytes
that is dependent on nocturnin (Ccrn4l ), a deadenylase that is
expressed rhythmically in the small intestine (Stubblefield
et al., 2012). In nocturnin-deficient (Noc/) mice, less tri-
glyceride and cholesterol are absorbed, resulting in reduced
triglycerides and lipoproteins in plasma (Douris et al., 2011).
In addition, enterocytes in Noc/ mice are deficient in
secreting lipid that is absorbed, resulting in increased lipid
storage relative to wild-type mice. Notably, the deficits
observed in Noc/ mice are not due to changes in MTP
regulation, suggesting that multiple clock-regulated pathways
regulate circadian variation in lipid absorption kinetics.SummaryThe circadian system coordinates opposing processes of
lipogenesis and fatty acid oxidation. This is achieved through
rhythmic activation and repression of clock-controlled meta-
bolic genes. The core clock proteins bind directly to genes
involved in lipid homeostasis, including transcription factors
(e.g., nuclear receptors) that couple the molecular clock with
metabolic function. Lipid pathways are under circadian con-
trol in all of the major metabolic tissues, and loss of clock
function results in abnormal fat storage and lipid transport,
altered circulating glucose and triglyceride levels, and deficits
in absorption of dietary lipids. Together, these studies establish
a key role for the molecular circadian clock in regulating lipid
homeostasis.
THE EMERGENCE OF CIRCADIAN
METABOLOMICS AND LIPIDOMICSExtensive circadian regulation of lipids revealed using
metabolomicsOver the past several years, an increasing number of studies
have used large-scale metabolite profiling (metabolomics)
to examine circadian-regulated metabolic pathways. When
combined with other systems biology approaches (e.g.,
transcriptomics), metabolomics can be used to provide a more
complete picture of circadian clock-controlled metabolic
function. In the first study to use liquid chromatographyemass
spectrometry (LCeMS) to profile the circadian time-course of
metabolite concentrations in mouse plasma, 14 different
lysophosphatidylcholine (LysoPC) species were identified that
showed circadian variation, with peak levels during the
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explained, at least in part, by circadian expression of hepatic
lipase (Lipc), which is a key enzyme in the LysoPC synthetic
pathway. Based on gene expression profiling in liver, Lipc
mRNA levels reach their peak shortly before the peak in
plasma LysoPC (Ueda et al., 2002). Using higher-density
time-sampling, mRNAs for other enzymes involved in
LysoPC synthesis have also been shown to cycle in liver,
including lecithin-cholesterol acyltransferase (Lcat), secreted
phospholipase A2 (Pla2), and endothelial lipase (Lipg)
(Hughes et al., 2009). Diurnal regulation of the liver tran-
scriptome and metabolome has also been examined in
Clock/ mice, revealing deficits in the time-course of bile
acid synthesis and the acyl-CoA thioesterase pathway relative
to wild-type mice (Eckel-Mahan et al., 2012). These studies
demonstrate that gene expression profiling and metabolomics
can be used together to characterize circadian-regulated lipid
metabolic pathways.
Recently, the differential effects of diet and meal timing on
metabolic function were examined using transcriptomics and
metabolomics approaches. Notably, when nocturnal mice are
given restricted access to a high-fat diet only during the day-
time, they gain weight at a faster rate than animals fed the
same diet during the nighttime (Arble et al., 2009). This
suggests that the timing of meal consumption can be a risk
factor for weight gain, and that it is better, at least from a
metabolic health standpoint, to eat during the usual active
phase (at night for mice). To test this hypothesis, diurnally
regulated mRNAs and metabolites in liver were examined in
mice given free access to a high-fat diet for 100 days, versus
animals that were given restricted access to the same diet for
8 h per day during the night (Hatori et al., 2012). Mice in both
feeding conditions consumed the same number of calories, but
there were marked differences in expression of genes involved
in lipid metabolism. For example, a much higher-amplitude
rhythm of Rev-erba mRNA was observed in livers of ani-
mals in the time-restricted feeding condition, leading to
reduced levels of fatty acid synthase (a REV-ERBa target)
and, consequently, decreased levels of free fatty acids. In
addition, animals that were fed only during the night showed
reduced mRNA levels for Pparg, and increased expression of
Cyp7a1, resulting in lower serum cholesterol and elevated
hepatic bile acids. In concert with changes in gene expression,
the time-course of more than 100 metabolites identified by MS
differed between groups. In mice with continuous access to
food, many metabolites implicated in fatty acid metabolism
were elevated at all times of day, thus attenuating (or masking)
diurnal variation in metabolites levels. Moreover, time-
restricted feeding prevents obesity, hyperinsulinemia, and
hepatosteatosis, which were observed in animals with free
access to high-fat food. Therefore, circadian timing of meals
can have a major impact on metabolic function and health. As
discussed below, this has potential implications for shift
workers who consume a substantial proportion of their daily
calories at night.
Metabolomics has been used only in the past couple of
years to examine the circadian time-course of metaboliteconcentrations in human plasma (Table 2; Fig. 3). In a group
of 10 middle-aged male subjects, gas chromatography-MS and
LC-MS were used to analyze metabolites in blood samples
collected over the span of 40 h (Dallmann et al., 2012). Par-
ticipants were studied under constant environmental condi-
tions, which included hourly consumption of isocaloric snacks
and continuous bed rest. Based on analyses of blood samples
that were pooled across subjects in 4-h bins, the concentrations
of 41 out of 281 metabolites (15%) exhibited circadian vari-
ation. The greatest proportion of oscillating metabolites
examined were lipids (>75%), in particular fatty acids. This
included essential fatty acids docosahexaenoate (DHA) and
eicosapentaenoate (EPA), which reached their highest levels
close to noontime. In a similar study in which blood was
collected every 2 h over a period of 36 h, LC-MS was used to
analyze circadian-regulated metabolites in plasma in a group
of 6 healthy males aged 20e23 years (Kasukawa et al., 2012).
Using a non-targeted metabolomics approach, more than 300
molecular ion peaks exhibited a circadian rhythm. For those
metabolites whose molecular identity was determined, several
belonged to the steroid hormone metabolism pathway,
including cortisol, cortisone, urocortisol-3-glucuronide, and
urocortisone-3-glucuronide. Several glycerophospholipid and
sphingolipid species were also identified as rhythmic, but most
of these lipids showed substantial individual variation in their
timing. In another study, the diurnal time-course of plasma
metabolites was examined in a group of 8 healthy males over a
24-h period (Ang et al., 2012). In contrast to the studies
described above, volunteers were exposed to ordinary room
light during the daytime and slept in darkness. Blood samples
were drawn every 3e6 h using an indwelling cannula, and LC-
MS was used to analyze plasma metabolites. Using a non-
targeted metabolomics approach, about 200 molecular ion
peaks showed diurnal variation. Of the 34 oscillating metab-
olites that were identified, the majority were either acylcar-
nitines or lysophospholipids. Acylcarnitines play a key role in
intracellular fatty acid transport required for b-oxidation and,
as mentioned above, the circadian clock regulates expression
of Cpt-1 in liver (Panda et al., 2002). CPT-1 converts long-
chain acyl-CoA to long-chain acylcarnitine, which allows
fatty acid transport across the inner mitochondrial membrane
by carnitine translocase. In mice, Cpt1a mRNA levels reach
their peak near the onset of the active phase, i.e., at the
beginning of night (Hughes et al., 2009). Interestingly, long-
chain acylcarnitines in human plasma reach their highest
levels near usual wake time (Ang et al., 2012), suggesting that
the rhythm of CPT1A might be inverted in mice and humans,
in order to promote fatty acid oxidation at the onset of
behavioral activity in both species.Using lipidomics to reveal novel regulatory circuitsGiven that lipid homeostasis is tightly regulated by circa-
dian clocks, several studies have used lipidomics-based ap-
proaches to better understand how the clock regulates lipid
metabolic pathways. As discussed above, the core clock pro-
tein PER2 interacts directly with PPARg and, in doing so,
Table 2
Lipids in human plasma that show circadian/diurnal variation
Fatty acyl Glycerolipid Glycerophospholipid Sphingolipid
10-heptadecenoate MAG(18:1) 1-eicosadienoylglycerophosphocholine Cer(d18:1/14:0)
13-HODE þ 9-HODE DAG(34:1) 1-palmitoylglycerophosphoinositol Cer(d18:2/16:0)
16-hydroxyhexadecanoate DAG(36:1) 2-linoleoylglycerophosphoethanolamine SM(d18:1/16:0)
3-hydroxydecanoate DAG(36:2) 2-oleoylglycerophosphoethanolamine SM(d18:1/18:1)
Arachidonate DAG(36:3) LysoPC(16:0) SM(d18:2/16:0)
Dihomo-linoleate TAG(48:0) LysoPC(18:2) N-eicosanoyl sphingosine
Dihomo-linolenate TAG(48:1) LysoPC(18:3)
Docosadienoate TAG(48:2) LysoPC(18:4) Sterol lipid
Docosahexaenoate TAG(48:3) LysoPC(20:1) 21-hydroxypregnenolone disulfate
Docosapentaenoate TAG(50:3) LysoPC(20:3) 5a-androstan-3a,17b-diol disulfate
Eicosapentaenoate TAG(50:4) LysoPC(20:5) Cholesterol sulfate
Linoleate TAG(51:2) LysoPE(16:0) Cortisol
Linolenate TAG(52:0) LysoPE(18:1) Cortisone
Nonadecanoate TAG(52:1) LysoPE(18:2) Dehydroepiandrosterone sulfate
Palmitate TAG(52:2) LysoPE(18:3) Pregnanediol
Palmitoleate TAG(52:3) LysoPE(20:4) Pregnenolone sulfate
a-hydroxyisocaproate TAG(52:4) LysoPE(22:4) Tetrahydrocorticosterone-3-glucuronide
Acetylcarnitine TAG(52:5) PG(18:1(9Z)/0:0) Urocortisol-21-glucuronide
Butyrylcarnitine TAG(52:6) PC(18:2/16:0) Urocortisone-3-glucuronide
cis-4-decenoylcarnitine TAG(53:2) PC(18:2/18:0)
Decanoylcarnitine TAG(53:3) PC(18:2/18:2) Prenol lipid
Dodecanoylcarnitine TAG(54:1) PC(32:2) 7a-hydroxy-3-oxo-4-cholestenoate
Hexanoylcarnitine TAG(54:2) PC(34:0p)
Octanoylcarnitine TAG(54:3) PC(34:1p)
Octenoylcarnitine TAG(54:4) PC(34:2p)
Oleoylcarnitine TAG(54:5) PC(34:4)
Palmitoylcarnitine TAG(54:6) PC(36:2p)
Propionylcarnitine TAG(54:7) PE(18:1/16:0)
Stearoylcarnitine TAG(56:3)
Tetradecadienoylcarnitine TAG(60:0)
Tetradecanoylcarnitine
Tetradecenoylcarnitine
Lipids are listed that were identified as rhythmic in human plasma, assessed across four studies that used lipidomics or other metabolomics approaches to analyze
metabolite concentrations across the circadian/diurnal cycle (Ang et al., 2012; Dallmann et al., 2012; Kasukawa et al., 2012; Chua et al., 2013). Only those lipids
that were identified as rhythmic in group-level analyses are shown. Cer, ceramide; DAG, diacylglycerol; MAG, monoacylglycerol; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PG, phosphatidylglycerol; SM, sphingomyelin; TAG, triacylglycerol. For glycerolipids (MAG, TAG, DAG), glycerophospholipids (PC,
PE, PG), Cer and SM, the number of acyl carbons and double bonds is indicated.
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Per2 knockout mice, the expression of adipogenic genes is
increased in white adipose tissue relative to wild-type mice
(Grimaldi et al., 2010). In the same study, lipidomics profiling
was performed in white adipose tissue to assess the impact of
PER2 loss of function. Using LC-MS, triglyceride levels in
white adipose tissue were sharply reduced in Per2 null mice,
whereas there were elevated levels of saturated and mono-
unsaturated very-long-chain fatty acids (SFA and MUFA
VLCFAs). This could be explained by increased expression of
fatty acid elongase (Elovl3) in Per2 null mice, as Elovl3 is atarget gene of PPARg, and ELOVL3 is implicated in the
synthesis of SFA and MUFA VLCFAs. Therefore, the circa-
dian clock can potentially regulate diurnal synthesis of
VLCFAs in adipose tissue via PER2-mediated repression of
PPARg.
In another study, the role of the circadian clock in adipose
tissue was examined in mice with adipocyte-specific deletion
of the Bmal1 gene (Ad-Bmal1/ mice) (Paschos et al., 2012).
Loss of clock function in adipose tissue resulted in increased
weight gain, and this was largely attributed to increased food
intake during the usual inactive phase. To examine potential
Fig. 3. Categories of lipids that show circadian/diurnal variation in human plasma.
A: Data were compiled across 4 studies that used lipidomics or other metabolomics approaches to analyze blood samples collected across the diurnal/circadian
cycle (Ang et al., 2012; Dallmann et al., 2012; Kasukawa et al., 2012; Chua et al., 2013). For those lipids that were identified as having a daily rhythm, the relative
fraction of lipids is shown across categories in each study, using the classification system recommended by the Lipid Metabolites and Pathways Strategy con-
sortium (LIPID MAPS; www.lipidmaps.org). Note that there was little overlap in the set of lipids examined across studies. B: Data are pooled across all four
studies, demonstrating extensive diversity in lipids that were identified as rhythmic in human plasma. FA, fatty acyls; GL, glycerolipids; GP, glycerophospholipids;
SP, sphingolipids; ST, sterol lipids; PR, prenol lipids.
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and feeding behavior, the authors performed lipid metabolite
profiling in adipose tissue across the diurnal cycle. In Ad-
Bmal1/ mice, the concentrations of triglycerides carrying
polyunsaturated fatty acids (PUFAs) decreased, which could
be due to reduced BMAL1-mediated activation of Elovl6 and
stearoyl-CoA desaturase 1 (Scd1) genes, which are involved in
the synthesis of long-chain PUFAs. A reduction in plasma
PUFA levels was also observed in Ad-Bmal1/ mice, in
particular during the middle of the active phase, which could
be explained by reduced clock-controlled expression of tri-
acylglycerol hydrolase (Ces1d ). The hypothalamic concen-
tration of PUFAs in Ad-Bmal1/ mice was also attenuated
during the middle of the active phase, whereas a PUFA-rich
diet restored normal body weight, feeding behavior, and hy-
pothalamic PUFA content. Together, these results suggest that
the adipose clock is critical for signaling nutrient status to
neuronal fatty acid-sensing neurons in the hypothalamus (Lam
et al., 2005), in order to regulate feeding behavior and energy
homeostasis.
Recently, lipidomics profiling in mouse plasma was used to
identify a novel signaling pathway linking fat metabolism in
liver and muscle (Liu et al., 2013). The nuclear receptor
PPARd, which is diurnally regulated in liver (Yang et al.,
2006), activates expression of lipogenic genes during the
night when nocturnal mice consume most of their food,
thereby mediating conversion of glucose to fats for storage or
use (Liu et al., 2011). When PPARd function is disrupted, fat
uptake in muscle is dysregulated only at night. To identify
candidate phospholipid mediators for the interaction between
PPARd activity, hepatic lipogenesis, and muscle fatty acid use,
plasma lipidomics profiling was performed in mice that had
liver-specific deletion of Ppard; that overexpressed PPARd; or
that had transient liver-specific knockdown of acetyl-CoA
carboxylase (Acaca), a rate-limiting enzyme in de novo lipo-
genesis (Liu et al., 2013). As expected, differences in the
lipidome were greatest between wild-type mice and Ppard null
mice at night, when PPARd is most active. Further compari-
sons of plasma lipids revealed a small subset of lipid species
that were altered in all three genetically-modified mouse
models. Most notably, levels of phosphatidylcholine(36:1),
subsequently identified as PC(18:0/18:1), were reduced duringthe night in serum of animals with liver-specific loss of PPARd
or ACACA, but increased in liver tissue from mice that over
express the Ppard gene, suggesting that PC(18:0/18:1) is
diurnally regulated by hepatic PPARd activity. The authors
went on to demonstrate that mice treated with PC(18:0/18:1)
showed reduced serum triglycerides and increased PPARa-
dependent fatty acid uptake into muscle cells. Moreover,
diabetic mice (db/db mice) treated with PC(18:0/18:1) showed
a reduction in fasting triglycerides, free fatty acids, and
glucose, and exhibited improved glucose tolerance relative to
untreated animals. These findings demonstrate that lipidomics-
based approaches can be used to characterize novel signaling
pathways important for regulating energy homeostasis.Circadian lipidomics in human plasmaPartial profiling of the circadian metabolome in human
plasma has revealed that a high proportion of oscillating me-
tabolites are lipids (Dallmann et al., 2012); however, only a
small number of lipids have been examined relative to the total
number of plasma lipid species (>500 lipids) (Quehenberger
et al., 2010). In addition, very little is known about how lipid
rhythms differ across individuals, as most studies have either
averaged metabolite levels across subjects or used pooled
blood samples. To address these limitations, lipidomics ap-
proaches were used to examine circadian-regulated plasma
lipids in a group of 20 healthy males (aged 21 to 28 years)
(Chua et al., 2013). In blood samples that were collected every
4 h over a span of 28 h, LC-MS was used to determine the time-
course of concentrations for 263 lipids, including glycerolipids
(diacyl and triacyl forms, 76 species), glycerophospholipids
(142 species), sphingolipids (43 species), and free cholesterol
and cholesterol esters. Group-level analysis showed that 35
lipid species (about 13%) exhibited circadian variation. The
majority of oscillating metabolites were triglycerides or di-
glycerides, which reached their highest levels near usual wake
time. A smaller number of phosphatidylcholines (PCs) were
also rhythmic, in particular plasmalogen PC, which exhibited
peak levels in the evening. At the level of individual subjects,
about 18% of lipid metabolite time-series were rhythmic
(Fig. 4A); however, there were marked individual differences
in the timing of rhythms, ranging up to 12 h apart for some lipid
Fig. 4. Circadian regulation of plasma lipids revealed using lipidomics-based approaches.
A: Circadian-regulated lipids are shown across 20 individuals, re-plotted from a previous study (Chua et al., 2013). The heat map shows the circadian time-course
for 935 individually-analyzed metabolite profiles. Colors show z-scored concentration levels for each metabolite time-series (red, high concentrations; blue, low
concentrations), with metabolites arranged by their peak concentration values. B: For those metabolites that were identified as rhythmic, the relative fraction is
shown across lipid classes, adjusted for the total number of lipids examined within each lipid category (purple, glycerolipids; green, glycerophospholipids; red,
sphingolipids). C: The percentage of lipids identified as rhythmic is shown for group-level and individual-level analyses. DAG, diacylglycerol; TAG, tri-
acylglycerol; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PG, phosphatidylglycerol; PS, phosphatidylserine; PA, phos-
phatidic acid; SM, sphingomyelin; Cer, ceramide; GluCer, glucosylceramide; GM3, ganglioside mannoside 3.
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glycerophospholipid and sphingolipid rhythms was highly
variable across subjects (Kasukawa et al., 2012), whereas
glycerolipid species almost always reached their peak in the
later part of the night or in the early morning. The set of
circadian-oscillating metabolites differed from one subject to
another, with median agreement of 20% for all pairwise
comparisons between subjects. These findings suggest that, for
many lipid species, there are strong individual differences in
the timing and amplitude of rhythms.
The aforementioned results highlight the importance of
examining circadian rhythms at the level of individual sub-
jects, as the results can differ substantially from those obtained
in group analyses (Fig. 4B and C). For example, only 11.3% of
PCs were identified as rhythmic based on group-level ana-
lyses, whereas 27.6% of PCs showed circadian variation when
assessed at the level of individual subjects (Fig. 4C). Evenmore striking, there were no sphingomyelin (SM) species
identified as rhythmic in group-level analyses, yet 19.5% of
SMs were shown to cycle in individually-analyzed data. To a
large degree, this occurred because, when individual rhythms
that were out of phase were averaged across subjects, they
effectively canceled each other out, resulting in no detectable
group rhythm. Despite large inter-subject variation in lipid
rhythms, subjects clustered into different phenotypic groups.
For example, half of participants showed a strong morning
predominance for peak lipid metabolite levels, whereas the
remaining subjects exhibited peak levels primarily in the
evening or with no phase predominance. Also, based on
consensus clustering analysis, subjects clustered into different
groups based primarily on strength of rhythmicity for a subset
of triglycerides, in particular those containing long-chain
PUFAs, and plasmalogen PCs. These results suggest that,
even in a relatively homogenous group of subjects (young
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based on differences in plasma lipid rhythms.SummaryMetabolite profiling studies have shown that the circadian
clock regulates lipid metabolite levels in liver, white adipose
tissue, and blood plasma. The timing and content of meals
influence the diurnal metabolome, including markers of lipid
metabolism. In addition, lipidomics approaches have been
used to identify pathways coupling the molecular clock to
fatty acid regulation in adipose tissue, and to examine
phospholipid-mediated signaling between liver and muscle. In
humans, metabolomics and lipidomics profiling in blood
plasma has revealed extensive diversity in circadian-regulated
lipids (Table 2), and there are strong inter-individual differ-
ences in the strength and timing of rhythms. Cycling lipids
include fatty acids and acylcarnitines, sterol lipids and their
derivatives, glycerolipids, glycerophospholipids, and sphin-
golipids, suggesting widespread circadian control of lipid-
mediated energy storage, transport, and signaling.
CLINICAL RELEVANCE AND FUTURE DIRECTIONSShift work, night eating, and metabolic dysfunctionHumans are naturally diurnal, but in modern society it is
increasingly common to eat meals, especially calorie-dense
foods, during nighttime hours. Shift workers in particular
often consume a substantial proportion of their total daily
calories between dusk and dawn. Based on epidemiologic
studies conducted over the past decade, it has become abun-
dantly clear that shift work increases disease risk. For
example, in the Nurses’ Health Study, it was found that
working 6 years on rotating shifts increases risk for coronary
heart disease by about 50% (Kawachi et al., 1995). In another
study, risk of stroke increased by 4% for every 5 years of
rotating night shift work (Brown et al., 2009), and the rate of
stroke-related mortality was found to be higher for individuals
with a longer history of shift work (Karlsson et al., 2005). The
rates of metabolic syndrome and type 2 diabetes are also
higher in shift workers (De Bacquer et al., 2009; Pan et al.,
2011; Monk and Buysse, 2013), with an increase in interme-
diate markers of cardiovascular risk including central obesity,
triglyceridemia, hyperglycemia, and hypertension (Sookoian
et al., 2007; De Bacquer et al., 2009; Esquirol et al., 2009).
Metabolic dysfunction in shift workers is thought to arise
from circadian misalignment with the imposed rest-activity
cycle, reduced circadian rhythm amplitude, chronic sleep
loss, or a combination of these factors. In principle, it is
possible to physiologically adapt to night work if sunlight is
avoided during the daytime, and there is sufficient exposure to
electrical lighting at night (Czeisler et al., 1990). For most
shift workers, this is impractical, as adopting a permanent
nocturnal lifestyle would interfere with social and family ob-
ligations. It is therefore common for shift workers to revert to
a day schedule on weekends or other stretches of free days.Consequently, the circadian system of many shift workers does
not fully align with the imposed shift work schedule (Wright
et al., 2013). Based on laboratory studies in humans, when
the circadian system is misaligned and food is consumed
during the usual hours of sleep, postprandial blood glucose
and insulin levels are higher relative to daytime meals,
whereas levels of the appetite-suppressant leptin decrease
(Scheer et al., 2009). Additionally, postprandial triglycerides
are higher for a standardized meal consumed during the bio-
logical night, as compared to the same meal consumed during
the biological daytime (Hampton et al., 1996; Ribeiro et al.,
1998). Put simply, due to circadian regulation of meta-
bolism, eating a Big Mac at night is not the same as eating a
Big Mac during the daytime.
For shift workers who remain synchronized with the solar
cycle, the circadian clock promotes wakefulness during the
daytime when sleep is attempted. This contributes to poor
quality and/or short-duration daytime sleep. Hence, not only
do many shift workers eat and work at a time-of-day that is out
of synch with the circadian clock, but they also frequently
experience reduced sleep, which itself is associated with dis-
rupted glucose regulation and changes in appetite (Morselli
et al., 2010). In laboratory studies, just a week of sleep re-
striction, i.e., sleeping less than the normal amount, results in
impaired glucose tolerance (Spiegel et al., 2005), and exposure
to 3 weeks of both sleep restriction (5.6 h of sleep per 24 h)
and circadian misalignment is associated with elevated post-
prandial glucose levels (Buxton et al., 2012). Sleep deficiency
also reduces the amplitude of circadian-oscillating mRNAs in
human blood, including core clock genes (Moller-Levet et al.,
2013). If metabolic tissues are similarly affected, this could
potentially lead to metabolic dysfunction similar to that
observed in clock gene-deficient mice (Li et al., 2012).
In future studies, large-scale metabolite profiling in shift
workers will help to elaborate mechanisms that link night
eating and circadian misalignment with metabolic dysfunc-
tion. As described earlier, the timing of food intake profoundly
affects liver metabolic function in mice fed a high-fat diet.
Whereas mice that are given free access to high-fat food
develop fatty liver disease, animals that consume the same diet
only during their usual active phase are protected against
metabolic dysfunction (Hatori et al., 2012). If these findings
translate to humans, shift workers could potentially reduce
their risk for metabolic disorders by reducing their nighttime
fat intake (e.g., by eating high-protein meals instead), or by
shifting the timing of their meals. Plasma lipidomics can
potentially be used to monitor treatment outcomes following
pharmacologic or behavioral interventions that aim to reduce
circadian misalignment and improve sleep.Obesity and circadian rhythmsWhilst disruption of circadian function can lead to weight
gain, obesity itself may contribute to reduced circadian
amplitude (van der Spek et al., 2012). In mice with a mutation
causing loss of function of leptin (ob/ob mice), diurnal activity
rhythms are attenuated and clock gene expression rhythms are
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Similarly, mice with a mutation in the long form of the leptin
receptor (db/db mice), which have a similar metabolic
phenotype as ob/ob mice, exhibit impaired clock gene function
in white adipose tissue (Caton et al., 2011). The obese Zucker
rat, which also has a mutation in the long form of the leptin
receptor, shows altered circadian rhythms of activity and core
body temperature (Murakami et al., 1995), as well as attenu-
ated clock gene rhythms in liver, but not in white adipose
tissue (Motosugi et al., 2011). The relationship between
obesity and reduced circadian rhythm amplitude could be
explained by increased food consumption during the usual
inactive phase. When mice are given free access to high-fat
food, they consume a greater proportion of their total daily
calories during the daytime than mice fed normal chow
(Kohsaka et al., 2007). This is associated with reduced clock
gene expression in liver and adipose tissue, as well as altered
diurnal expression of nuclear receptors and genes involved in
lipid metabolism, including SREBP-1c, acetyl-CoA carbox-
ylase, fatty acid synthase, and fatty acid binding protein 4
(Fab4). In morbidly obese patients, circadian rhythms in clock
gene expression are sustained in fat explants, and in serially-
collected white adipose tissue biopsies (Gomez-Abellan
et al., 2008; Otway et al., 2011); however, the effects of
obesity and high-fat food consumption on circadian metabolic
rhythms have not been systematically examined in humans.
Therefore, in future work it will be important to evaluate the
effects of diet, meal times, and body weight on clock-regulated
metabolic pathways. To be sure, such efforts will be aided by
lipidomics profiling in patient populations.Circadian-based treatment of metabolic diseasesMany clinical symptoms and disease processes show a
distinct daily profile. It has long been recognized, for example,
that acute myocardial infarction (AMI) and sudden cardiac
death occur most frequently in the early morning (Portaluppi
and Lemmer, 2007). Remarkably, in the first few days
following transition to daylight saving time, the incidence of
AMI increases, suggesting that even a small amount of
circadian misalignment or sleep loss negatively impacts car-
diovascular function (Janszky and Ljung, 2008). Also, as
discussed above, the circadian rhythm of plasma triglycerides
reaches its peak near usual wake time (Morgan et al., 1998;
Chua et al., 2013), and postprandial triglyceride levels are
higher for meals consumed at night (Hampton et al., 1996;
Ribeiro et al., 1998). In shift workers, these factors could
contribute to postprandial lipemia, which is linked to athero-
sclerosis and considered a risk factor for cardiovascular dis-
ease. The observation that disease symptoms vary across the
circadian cycle has led to targeted time-of-day treatment
schedules (Zhu et al., 2008). As an example, it commonly
recommended that cholesterol-lowering statins with short half-
lives be taken in the evening, in order to counteract the in-
crease in cholesterol synthesis that occurs during the night.
This is based, in part, on clinical trials that have shown that
morning cholesterol levels are lower when simvastatin is takenin the evening, as compared to in the morning (Saito et al.,
1991; Lund et al., 2002; Wallace et al., 2003). As might be
expected, statin administration induces substantial changes in
the lipidome when assessed on the morning following bedtime
dosing (Krauss et al., 2013); however, no studies have exam-
ined the effects of statins on the diurnal time-course of plasma
lipids.
Recently, synthetic REV-ERB agonists have been devel-
oped, which alter circadian behavioral patterns and clock gene
expression rhythms in mice. Treatment with REV-ERB ago-
nists induces weight loss in mice fed a high-fat diet relative to
those given vehicle treatment, and this is accompanied by
decreased plasma triglycerides, cholesterol, free fatty acids,
and glucose (Solt et al., 2012). These studies demonstrate that
REV-ERB ligands can potentially be used to reset circadian
rhythms and to reduce fat mass, which is clinically relevant for
obese shift workers. As discussed earlier, treatment of obese
mice with PC(18:0/18:1), which activates PPARa-mediated
fatty acid uptake in muscle tissue, also reduces fasting tri-
glycerides and free fatty acids and improves glucose tolerance
(Liu et al., 2013). These results are generally consistent with
the effects of hypolipidemic fibrate drugs, which have been
shown to activate PPARa and to induce Rev-erba gene
expression (Gervois et al., 1999). Although PC(18:0/18:1) was
shown to be diurnally-regulated in mice, it should be pointed
out that in a recent study only 4 out of 20 human subjects
showed circadian variation in plasma PC(36:1) concentration
levels (Chua et al., 2013). Additional studies are needed to
determine whether the PC(18:0/18:1) signaling pathway
identified in mice is conserved for diurnal regulation of lipid
metabolism in humans.
The circadian system regulates xenobiotic metabolism and
hence daily variation in the potency and toxicity of drugs (Levi
and Schibler, 2007). Therefore, patient outcomes can poten-
tially be improved if medications are timed appropriately ac-
cording to an individual’s circadian phase, i.e., by using
chronotherapy-based treatment approaches. Although a pa-
tient’s circadian phase is rarely assessed at the time of treat-
ment, a novel metabolomics-based method has been developed
to address this issue (Kasukawa et al., 2012). In any given
tissue, hundreds of individual mRNAs and metabolites show
circadian variation but reach their peak levels at different times
of day. Since the relative abundance of different cycling
mRNAs and metabolites changes across the circadian cycle, it
is possible (at least theoretically) to estimate an individual’s
circadian phase at the time of sample collection based on the
concentrations of mRNAs or metabolites contained therein.
This was first demonstrated for cycling mRNAs in mouse liver
(Ueda et al., 2004). Based on each animal’s gene expression
profile in liver at the time of death, circadian phase could be
estimated to within an hour in most cases. This method was
later extended to estimate circadian phase of blood samples
collected in mice and humans using non-targeted plasma
metabolomics profiling (Minami et al., 2009; Kasukawa et al.,
2012). Using mass spectrometry, most molecular ion peaks
that were identified as rhythmic reached their highest levels in
the late biological evening or morning, corresponding to the
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collected 12 h apart, circadian phase could be estimated to
within about 1.5 h in mice, and to within 3 h in humans. At
present, this method could potentially be used to detect gross
circadian misalignment, e.g., resulting from jet lag or shift
work. If the method is further developed and optimized,
however, circadian metabolomics and/or lipidomics might
eventually be used to personalize medication schedules in
order to improve chronotherapy-based treatments.Limitations and future directionsTo date, only a small number of studies have used lip-
idomics approaches to examine circadian regulation of lipids
in blood or metabolic tissues. It should be noted, however, that
none of these studies profiled the circadian lipidome in its
entirety. Lipids exhibit staggering chemical diversity, and
hence it is not possible to measure the lipidome in a single
experiment using a single mass spectrometric technique
(Wenk, 2010). In humans, the plasma lipidome comprises
more than 500 lipid species (Quehenberger et al., 2010). To
date, however, there has been little overlap in the set of lipids
examined across studies (Ang et al., 2012; Dallmann et al.,
2012; Kasukawa et al., 2012; Chua et al., 2013), and only a
handful of lipids have been identified as rhythmic (based on
group-level analyses) in more than one study, namely arach-
idonic acid, DHA, dodecanoylcarnitine, octanoylcarnitine,
lysoPC(16:0), cortisol, cortisone, and pregnenolone sulfate.
However, an important consideration is that different methods
and thresholds were used for assessing rhythmicity across
studies. In future work, it will be important to show that the set
of lipid species identified as rhythmic in one laboratory can be
reproduced by other laboratories using similar methodology.
Related to this point, the circadian lipidome should be
reproducible within the same individual, but only one study
has performed circadian metabolomics profiling in the same
subjects (n ¼ 6) on two separate occasions (Kasukawa et al.,
2012).
Thus far, studies that used lipidomics approaches to analyze
human plasma have not examined the source of circadian-
regulated plasma metabolites. As discussed above, the circa-
dian clock regulates de novo synthesis of lipids in metabolic
tissues, as well as absorption and catabolic breakdown of di-
etary lipids. In humans given hourly isocaloric snacks across
the circadian cycle, plasma triglycerides increase during the
later part of the biological night (Morgan et al., 1998; Chua
et al., 2013). This could be explained by a circadian increase
in lipid absorption and secretion from enterocytes, an increase
in triglyceride synthesis by the liver, or a reduced capacity to
catabolize dietary fat that is absorbed. The source of oscil-
lating lipids could be examined by manipulating the content
and timing of meals, or by exposing subjects to fasting and fed
conditions. As noted elsewhere, fasting-feeding cycles can
modulate molecular clock function via nutrient-sensing path-
ways, and hence the circadian metabolome measured in
plasma may be influenced by the distribution and timing of
food consumption (Sahar and Sassone-Corsi, 2012). A moregeneral limitation of prior work is that the individual fatty acyl
composition of most circadian-regulated glycerolipids and
glycerophospholipids was not determined. As an example,
PC(32:2) exhibited circadian variation in human plasma (Chua
et al., 2013), but it is not clear if this was due to circadian
oscillations in levels of PC(16:1/16:1), PC(16:2/16:0), or other
combinations of PC containing a total of 32 fatty acyl carbons
and 2 double bonds. If the specific acyl chain composition is
taken into account, it is possible that many more sub-species
of lipids will be identified as being under circadian control,
which might provide additional insight into the relationship
between clock function and lipid metabolism.
To date, surprisingly few studies have examined, in any
species or tissue, individual differences in the circadian
metabolome or lipidome. Therefore, an important initiative in
future studies will be to characterize between-subject differ-
ences in circadian-regulated metabolism, and to identify
sources of individual variation. For example, the effects of
sex, aging, diet, and exercise status on diurnal regulation of
lipids should be examined, as each of these factors has been
shown to influence circadian behavior and/or clock function.
Recent studies indicate that individual differences in the
plasma lipidome are partially explained by genetic variation.
It has been shown, for example, that the plasma lipidome is
more similar between monozygotic twin pairs, as compared to
dizygotic twins or non-twin siblings (Draisma et al., 2008,
2013). Also, based on results of a genome-wide association
study (Gieger et al., 2008), differences in the plasma metab-
olome and metabolic traits, including the capacity to catabo-
lize triglycerides, are associated with genetic variation in lipid
metabolic enzymes. It remains to be determined, however,
whether individual differences in the circadian lipidome
associate with differences in genotype. Genetic variation in
the core clock genes, or clock-controlled genes involved in
lipid metabolism, could potentially alter the timing and
amplitude of lipid metabolic rhythms. Preliminary findings
suggest that individuals cluster into different groups based on
strength of circadian rhythmicity for a subset of triglycerides
and plasmalogen PCs (Chua et al., 2013), but such differences
could arise from genetic variation or lifestyle factors that were
not taken into account. Genetic contributions to the circadian
lipidome could be examined by comparing circadian regula-
tion of plasma lipids in monozygotic and dizygotic twin pairs.
If individual differences in the circadian lipidome are shown
to be heritable and trait-like, this would open up new possi-
bilities for exploring the molecular basis for metabolic
vulnerability to night eating and shift work. Similarly, lip-
idomics could be used to examine differences in circadian
responses to medications that target lipid pathways, e.g., sta-
tins or fibrates, and to better characterize the mode of action
of such drugs.
CONCLUDING REMARKS
The circadian system plays an integral role in coordinating
lipid metabolic function with feeding and rest-activity cycles.
The circadian clock regulates expression of genes involved in
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tabolites in liver, adipose tissue, and blood. In the past few
years, a growing number of studies have used lipidomics and
other metabolomics approaches to examine the diurnal time-
course of lipid concentrations in metabolic tissues. These
studies have revealed extensive circadian regulation of lipid
metabolic pathways. In addition, circadian lipidomics has
been used, in combination with other experimental ap-
proaches, to identify novel regulatory circuits involved in lipid
metabolism. The timing of food consumption modulates the
diurnal metabolome in liver, suggesting that rhythmic feeding
signals alter clock-regulated metabolic outputs. In humans,
more than a hundred oscillating lipids have been identified in
plasma, most notably fatty acids, acylcarnitines, glycerolipids,
glycerophospholipids, and cholesterol derivatives; however,
the timing and amplitude of lipid rhythms can vary markedly
across subjects. Future studies should examine factors that
contribute to individual differences in the circadian lipidome,
as well as the clinical relevance of individual variation in
circadian-oscillating lipids. Looking forward, circadian lip-
idomics profiling will be increasingly used to assess the effects
of environmental and genetic factors on circadian-regulated
lipid metabolic pathways. In particular, lipidomics and other
metabolomics approaches can be used to assess the impact of
shift work, night eating, and obesity on circadian metabolic
function, and to monitor circadian phase-dependent responses
to drugs that target lipid pathways.ACKNOWLEDGEMENTS
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